Furthermore, treatment with the NLRP3 inhibitor MCC950 alleviates the severity of arthritis in mouse models [7], indicating the pivotal role of the NLRP3 inflammasome in RA pathogenesis. The gene discussed is NLRP3; the disease is rheumatoid arthritis.